Browsing Category

64085 posts
RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients

RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients

YANTAI, China, Dec. 18, 2023 /PRNewswire/ — RemeGen Co. Ltd. ("RemeGen" or…
Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries

Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries

10+ Emerging Markets, Japan & ANZ Transition in Final Phase KUALA LUMPUR,…
Accura Scan to fortify eKYC & ID verification with Contactless Finger Biometrics & Document Liveness Check

Accura Scan to fortify eKYC & ID verification with Contactless Finger Biometrics & Document Liveness Check

DUBAI, UAE, SINGAPORE, and LAWRENCEVILLE, Ga., Dec. 18, 2023 /PRNewswire/ — In…
Ubitus collaborates with HTC to launch Taiwan's first hip-hop virtual holographic concert

Ubitus collaborates with HTC to launch Taiwan's first hip-hop virtual holographic concert

TOKYO, Dec. 18, 2023 /PRNewswire/ — Ubitus K.K., a global cloud streaming…
NuVolta Qi2 MPP Module Global Debut

NuVolta Qi2 MPP Module Global Debut

SHANGHAI, Dec. 18, 2023 /PRNewswire/ — WPC began the Soft-Launch certification testing from…
Beijing Review：Aiming High

Beijing Review：Aiming High

BEIJING, Dec. 18, 2023 /PRNewswire/ — On December 31, 2022, while extending…